CD55 Antikörper (Biotin)

Produktnummer ABIN3071840

Dieser Maus Monoklonal Antikörper erkennt spezifisch CD55 in FACS. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CD55 Antikörper (Biotin) (ABIN3071840)

Target: CD55 (Complement Decay-Accelerating Factor (CD55))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD55 Antikörper ist konjugiert mit Biotin

Applikation: Flow Cytometry (FACS)

Güteklasse: GMP Grade

Klon: F4-29D9

Produktdetails anti-CD55 Antikörper (Biotin)

Verwendungszweck: CD55 Biotin Antibody

Produktmerkmale: The clone F4-29D9 binds with a single chain 70 kDa glycoprotein and identified as CD55 (also known as decay accelerating factor, DAF). CD55 is widely expressed on cells throughout the body including leukocytes, erythrocytes, epithelium, endothelium, and fibroblasts. It is a Glycosyl phosphatidylinositol anchored (GPI-anchored) protein and inhibits autologous complement cascade activation. CD55 also serves as receptor for CD97, echovirus and Coxsackie B virus. Anticd55 is a useful marker for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH).

Aufreinigung: Purified

Reinheit: >95 %

Immunogen: Human umbilical vein endothelial cells

Isotyp: IgG1, kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: PBS pH 7.2, 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: 2-8°C, Conjugated antibodies should never be frozen.

Details zu CD55

Target: CD55 (Complement Decay-Accelerating Factor (CD55))

Andere Bezeichnung: CD55

NCBI Accession: NP_000565, NM_000574, NP_001108224, NM_001114752, NP_001287832, NM_001300903, NP_001287833

UniProt: P08174

Pathways: Komplementsystem, Regulation of Leukocyte Mediated Immunity